NASEM report offers strategies to make prescription drugs more affordable

Nov 30, 2017 - 09:17 AM

Access to effective and affordable medicines is necessary for public health, social equity, and economic development, but the biopharmaceutical sector is not meeting that need, according to a report released today by the National Academies of Sciences, Engineering, and Medicine. “Our report seeks to address the market failures that currently permeate the biopharmaceutical sector, such as lack of competition due to distortions in the application of the patent protection process, the imbalance between the negotiating power of suppliers and purchasers, and the convoluted structure of the supply chain,” the authors note. The report offers eight recommendations with 27 actions to improve the affordability of prescription drugs without discouraging the development of new and more effective drugs for the future. Among other measures, the report recommends improving methods for assessing the value that drugs provide and ensuring that incentives to develop drugs for rare diseases are not extended to widely sold drugs; taking actions to continually foster greater access to off-patent generic drugs; and discouraging direct-to-consumer advertisements for prescription drugs. 

Related News Articles

Headline
CMS approves Ariz. Medicaid waiver with work requirement
The Centers for Medicare…
Perspective
Perspective: Turning the Tide on the Prescription Drug Spending Crisis
Last week, I shared a few areas where we can advance health in America this year, even in a divided Congress.
Headline
FDA takes steps to spur OTC versions of naloxone
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug…
Headline
CDC: Rural patients more likely to receive opioid prescription
Patients in the most rural counties had an 87 percent greater chance of receiving an opioid prescription from their primary care provider between January 2014…
Headline
AHA Releases New Report that Shows Continued Rising Drug Prices and Drug Shortages are Disrupting Patient Care, Hospital Budgets
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Headline
AHA recommends certain changes to Medicaid/CHIP managed care rule
AHA said it generally supports CMS’ efforts to grant greater state-level flexibility and reduce regulatory burden, but urged the agency to ensure Medicaid…